Search results for: Antibiotics

Incentives for New Drugs and Vaccines to Tackle Anti-Microbial Resistance

16 May 2017

Resistance to antibiotics is growing. Additional R&D is required. Both Transferable Intellectual Property Rights and Market Entry Rewards should be explored for use in Europe as a regional “pull” incentive….

Patient Preferences for Diagnostic Tests Aimed at Managing Antimicrobial Resistance

7 October 2019

…2017. Time for a Change in How New Antibiotics are Reimbursed: Development of an Insurance Framework for Funding New Antibiotics based on a Policy of Risk Mitigation. Health Policy. DOI….

Antimicrobial Resistance (AMR)

What is AMR?  Antimicrobial Resistance (AMR) occurs when microorganisms such as bacteria, viruses, fungi, and parasites evolve, rendering medications ineffective. Overuse and misuse of antibiotics and antimicrobial drugs contribute to…

New Antimicrobial Drugs: EU Policy Options

4 October 2010

Antimicrobial resistance to drugs is a growing global public health issue. The EU began a discussion in 2009 about which policies can best encourage the development of new antibiotics. New…

Incentives for New Drugs to Tackle Anti-Microbial Resistance

1 May 2017

Resistance to antibiotics is growing, posing a major health risk in rich and poor countries. Additional ways of rewarding R&D are required. Mechanisms designed to encourage companies to undertake R&D…

OHE at ISPOR’s 20th Annual European Congress: Presentations

…of Health Economics   Adrian Towse presented work from the Office of Health Economics adapting HTA approaches to assess the value of antibiotics, building on a recent Discussion Forum in…

From STEDI to STRIDES: Valuing broader health-system benefits of AMR diagnostics

21 July 2025

…(AMS) refers to a coordinated, system-wide approach to promoting and monitoring the optimal use of antibiotics.  The role of diagnostics in curbing AMR Diagnostics are critical in the fight against…

Plan For A New EU Pharmaceutical Legislation: What Will It Mean For Pharmaceutical Innovation?

12 April 2024

…data protection for the first time. Finally, the Commission proposed introducing a reward system for the development of novel antibiotics to combat AMR, structured around transferable data exclusivity vouchers (TEVs) which…

OHE at ISPOR’s 20th Annual European Congress in Glasgow

2 November 2017

…subject central to many of OHE’s research projects. We’ll be participating in 11 different sessions across 4 days, on a variety of topics including MCDA, EQ-5D, orphan drugs, antibiotics, and…